(RTTNews) - SeaStar Medical Holding Corp. (ICU) on Thursday said that critically ill pediatric patients with sepsis-associated acute kidney injury who received QUELIMMUNE (SCD-PED) therapy had significantly higher survival rates than a historical comparison group in the primary a
Nous affichons publiquement l'idee principale. Creez un compte gratuit pour lire l'article complet, l'enregistrer, le commenter et le relier au contexte marches et OSINT.